DFP Healthcare Acquisitio... (DFPHU)
undefined: DFPHU
· Real-Time Price · USD
10.26
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM
DFP Healthcare Acquisitions Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 |
|---|---|---|---|---|
| Capitated Revenue Revenue | 18.84M | 17.5M | 53.87M | 14.81M |
| Capitated Revenue Revenue Growth | +7.71% | -67.53% | +263.69% | n/a |
| Clinical Research Trials And Other Revenue Revenue | 1.34M | 2.04M | 6.67M | 1.94M |
| Clinical Research Trials And Other Revenue Revenue Growth | -34.57% | -69.36% | +244.20% | n/a |
| Dispensary Revenue Revenue | 62.57M | 49.29M | 131.71M | 48.21M |
| Dispensary Revenue Revenue Growth | +26.94% | -62.57% | +173.19% | n/a |
| Fee For Service Revenue | 37.05M | 35.57M | 101.26M | 34.94M |
| Fee For Service Revenue Growth | +4.15% | -64.87% | +189.81% | n/a |
| Health Care, Patient Service Revenue | 55.89M | 53.07M | 155.13M | 49.75M |
| Health Care, Patient Service Revenue Growth | +5.32% | -65.79% | +211.81% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 26.91M | 25.38M | 24.86M | 26.65M | 27.87M | 28.45M | 28.09M | 28.2M | 28.73M | 28.83M | 29.57M | 31.96M | 28.35M | 29.81M | 48.24M | 12.73M | 11.21M | 11.18M | 41.57M | 148.48K | 8.55M | 8.82M | 8.83M |
| Selling, General, and Administrative Revenue Growth | +6.03% | +2.08% | -6.71% | -4.40% | -2.04% | +1.29% | -0.41% | -1.81% | -0.36% | -2.51% | -7.48% | +12.75% | -4.89% | -38.22% | +278.99% | +13.54% | +0.31% | -73.11% | +27894.50% | -98.26% | -3.12% | -0.13% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |